期刊文献+

外科脓毒症免疫功能障碍的监测与调理策略 被引量:6

Immune dysfunction in the development of sepsis: from monitoring of immune status to immunomodulatory strategy
原文传递
导出
摘要 脓毒症是一种严重的感染并发症,通常是由微生物感染、严重烧(创)伤及外科大手术对机体应激打击等引发,并伴有全身炎症反应综合征和MODS,从而导致在ICU中的高发病率及病死率.长期以来,由于临床医师对于外科打击后机体免疫功能障碍的确切机制及其在脓毒症中的作用认识不足,临床上缺乏切实有效的免疫功能监测手段和调理措施.近年来随着对脓毒症发病本质的逐步了解,临床医师已认识到脓毒症发病机制非常复杂,除感染与炎症过程外,机体免疫功能障碍参与了脓毒症的病理生理过程,且发挥关键作用.因此,对烧(创)伤、外科大手术后脓毒症机体免疫状况的合理监测,寻求新的有效防治途径,对于严重脓毒症的早期识别、诊断和干预,降低重症患者病死率及提高患者生命质量具有重大意义. Sepsis is a severe complication which is usually caused by microbial infection,severe burns or trauma and major operations.Patients with sepsis were usually complicated with systemic inflammatory response and multi-organ dysfunction syndrome,which is the leading cause of death in the intensive care units.However,the main immunoregulatory mechanisms underlying severe sepsis remain unclear,and effective methods for monitoring immune status and immunomodulatory strategies need to be investigated.In recent years,the understanding of the mechanism of sepsis has been developed.Clinicians have learned that immune dysfunction took part in the pathophysiological process of sepsis.Therefore,rational monitoring of immune status in patients with severe sepsis after burns or major operation,seeking effective ways for diagnosis,treatment and intervention are of great significance in decreasing the mortality and improving the life quality.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2014年第7期516-519,共4页 Chinese Journal of Digestive Surgery
基金 国家自然科学基金(81130035、81372054、81121004) 国家重点基础研究发展计划(973计划)项目(2012CB518102) 军队“十二五”计划重大项目(AWS11J008、BWS12J050)
关键词 脓毒症 免疫功能 监测 免疫调理 Sepsis Immune function Monitoring Immunomodulation
  • 相关文献

参考文献24

  • 1Luan YY,Dong N,Xie M,et al.The significance and regulatory mechanisms of innate immune cells in the development of sepsis[J].J Interferon Cytokine Res,2014,34(1):2-15.
  • 2Unnewehr H,Rittirsch D,Sarma JV,et al.Changes and regulation of the C5a receptor on neutrophils during septic shock in humans[J].J Immunol,2013,190(8):4215-4225.
  • 3Pillay J,Kamp VM,van Hoffen E,et al.A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1[J].J Clin Invest,2012,122(1):327-336.
  • 4Hotchkiss RS,Monneret G,Payen D.Sepsis-induced immunosuppression:from cellular dysfunctions to immunotherapy[J].Nat Rev Immunol,2013,13 (12):862-874.
  • 5Zhu XM,Yap YM,Liang HP,et al.Effect of high mobility group box-1 protein on apoptosis of peritoneal macrophages[J].Arch Biochem Biophys,2009,492(1/2):54-61.
  • 6董宁,姚咏明,曹玉珏,贺立新,于燕,柴家科,盛志勇.大面积烧伤脓毒症患者T淋巴细胞免疫功能的改变及临床意义[J].中华烧伤杂志,2007,23(2):84-87. 被引量:14
  • 7Tabas I,Glass CK.Anti-inflammatory therapy in chronic disease:challenges and opportunities[J].Science,2013,339(6116):166-172.
  • 8姚咏明.重视脓毒症免疫功能的负向调控作用[J].中华急诊医学杂志,2012,21(2):117-119. 被引量:12
  • 9Zhang QH,Chen Q,Kang JR,et al.Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury[J].J Neuroinflammation,2011,8:118.
  • 10Zhu XM,Yap YM,Liang HP,et al.The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats[J].J Interferon Cytokine Res,2009,29 (10):677-686.

二级参考文献97

共引文献177

同被引文献54

  • 1姚咏明,盛志勇.金黄色葡萄球菌外毒素与脓毒症及多器官损害[J].中华创伤杂志,2004,20(12):711-714. 被引量:18
  • 2李利,方强.核因子-κB的结构和功能研究及与全身炎症反应综合征的关系[J].国外医学(临床生物化学与检验学分册),2005,26(11):792-794. 被引量:6
  • 3姚咏明,黄立锋,林洪远.进一步提高对脓毒症免疫机制及调理策略的认识[J].创伤外科杂志,2007,9(1):4-7. 被引量:37
  • 4ARISE Investigators; ANZICS Clinical Trials Group, Peake SL,Delaney A, et al. Goal-directed resuscitation for patients with early septic shock[J].N Engl J Med, 2014, 371(16): 1496-1506.
  • 5Jawad I, Luksic I, Rafnsson S B. Assessing available information on the burden of sepsis: global estimates of incidence,prevalence and mortality[J]. J Glob Health,2012, 2(1):010404.
  • 6Armstrong S M, Mubareka S, Lee W L. The lung microvascular endothelium as a therapeutic target in severe influenza[J]. Antiviral Res, 2013, 99(2): 113-118.
  • 7Cohen J, Opal S, Calandra T. Sepsis studies need new direction[J]. Lancet Infect Dis,2012, 12(7): 503-505.
  • 8Morel O, Jesel L, Freyssinet J M, et al. Cellular mechanisms underlying the formation of circulating microparticles[J]. Arterioscler Thromb Vasc Biol,2011, 31(1): 15-26.
  • 9Meziani F, Delabranche X, Asfar P, et al. Bench-to-bedside review: circulating microparticles-a new player in sepsis?[J]. Crit Care, 2010, 14(5): 236.
  • 10Distler J H, Huber L C, Gay S, et al. Microparticles as mediators of cellular cross-talk in inflammatory disease[J]. Autoimmunity, 2006, 39(8): 683-690.

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部